Filter by:
Rejuva
ADA, 2025
Single-Dose GLP-1-Based Pancreatic Gene Therapy Prevents Obesity and Diabetes in High-Fat Fed Mice
Kieffer, et al., presented at the American Diabetes Association’s 85th Scientific Sessions
Rejuva
American Society of Cell and Gene Therapy 2025
Endoscopic Ultrasound-Guided Delivery of Human Glucagon-like Peptide-1 Pancreatic Gene Therapy: Safety and Feasibility in a Porcine Model
Fitzpatrick, et al., presented at the American Society of Cell and Gene Therapy (ASGCT) 2025
Rejuva
Digestive Disease Week, 2025
Feasibility and Safety of Endoscopic Ultrasound-Guided Delivery of Human GLP-1 Pancreatic Gene Therapy in a Porcine Model
Thompson et al., presented at Digestive Disease Week (DDW) 2025
Rejuva
WCIRDC, 2024
Feasibility and Safety of Novel Endoscopic Ultrasound-Guided Delivery of Human GLP-1 Pancreatic Gene Therapy in Pigs
Kieffer et al., presented at the 22nd World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Rejuva
ObesityWeek, 2024
Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves Metabolism in Obese Mice
Rajagopalan, et al., presented at The Obesity Society’s Annual Meeting at ObesityWeek 2024
Rejuva
ADA, 2024
Single-Dose GLP-1-Based Pancreatic Gene Therapy Durably Maintains Body Composition and Glycemia After Semaglutide Withdrawal in a Murine Model of Obesity
Rajagopalan, et al., presented at the American Diabetes Association’s 84th Scientific Sessions
Rejuva
DDW, 2024
Single-dose GLP-1-based Pancreatic Gene Therapy Maintains Weight Loss After Semaglutide Withdrawal and Reduces Hepatic Triglycerides in a Murine Model of Obesity
Rajagopalan, et al., presented at Digestive Disease Week, Washington, D.C., May 2024
Rejuva
WCIRDC, 2023
Single-dose GLP-1-based Pancreatic Gene Therapy Maintains Weight Loss After Semaglutide Withdrawal in a Murine Model of Obesity
Liou, et.al. presented at World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, Universal City, CA, Dec 2023
Rejuva
EASD, 2023
Pancreatic Gene Therapy Durably Improves Glycaemia and Delays Disease Progression in a Murine Model of Type 2 Diabetes
Rajagopalan, et al. presented at European Association for the Study of Diabetes (EASD) 2023, Hamburg, German, October 2023